Results 161 to 170 of about 45,261 (260)

Optimizing non-invasive vagus nerve stimulation for treatment in stroke. [PDF]

open access: yesNeural Regen Res
Baig SS   +7 more
europepmc   +1 more source

Deep brain stimulation of the centromedian nucleus for drug‐resistant epilepsy in children: Quality‐of‐life and functional outcomes from the CHILD‐DBS registry

open access: yesEpilepsia, EarlyView.
Abstract Objective Deep brain stimulation of the centromedian nucleus of the thalamus (CM‐DBS) is an investigational, off‐label treatment for drug‐resistant epilepsy (DRE) in children. Although emerging evidence supports its safety and efficacy for select indications, the effect of CM‐DBS on quality of life and functional outcomes such as school ...
Karim Mithani   +21 more
wiley   +1 more source

Developmental and epileptic encephalopathy in patients with epilepsy due to hypothalamic hamartomas

open access: yesEpilepsia, EarlyView.
Abstract Objective What factors influence cognition and behavior in patients with epilepsy caused by hypothalamic hamartoma (HH)? Methods We conducted a retrospective study of 103 patients referred to the Epilepsy Center in Freiburg, Germany, over the past 24 years.
Kathrin Wagner   +9 more
wiley   +1 more source

Neural simulation for auricular vagus nerve stimulation [PDF]

open access: yes, 2016
Joseph, Wout   +6 more
core  

Frequency‐specific alterations in brain connectivity induced by pulvinar stimulation

open access: yesEpilepsia, EarlyView.
Abstract Objective Deep brain stimulation (DBS) is emerging as a promising therapy for patients with drug‐resistant epilepsy, particularly those who are either unsuitable for or unresponsive to resective surgery. The potential benefit of DBS in these patients may stem from its ability to reduce excessive brain functional connectivity (FC).
Emma Acerbo   +8 more
wiley   +1 more source

Two‐year outcomes of epicranial focal cortex stimulation in pharmacoresistant focal epilepsy

open access: yesEpilepsia, EarlyView.
Abstract Objective This study was undertaken to report on the long‐term safety and efficacy of epicranial focal cortex stimulation (FCS) using the EASEE device as adjunctive neuromodulatory therapy in improving seizure control in adults with pharmacoresistant epilepsy originating from one predominant epileptogenic zone.
Andreas Schulze‐Bonhage   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy